Heart Arrhythmia: Symptoms, Tests and Treatment

Heart arrhythmia: understanding the rhythm and choosing the next step

A heart arrhythmia is a problem with the timing or pattern of the heartbeat. Some rhythms need little more than observation after assessment; others require medicines, a procedure or emergency treatment. The useful question is not simply whether a pulse is fast, slow or irregular. It is what rhythm is present, whether it is affecting circulation, and whether there is an underlying heart condition.

For a broader overview of symptoms that need assessment, see our guide to heart problem warning signs.

What changes when the heart rhythm changes?

The heart has two upper chambers, called atria, and two lower pumping chambers, called ventricles. Normally, an electrical signal begins in the sinus node and travels through the heart in an organized sequence. An arrhythmia can involve signals starting elsewhere, circulating repeatedly, arriving too early or travelling too slowly. Rate and regularity describe different features: a fast rhythm can be regular, and an irregular rhythm need not be especially fast. Normal sinus rhythm also changes with circumstances. Exercise can speed it up; sleep and athletic training can slow it down. A number on a pulse display, without the circumstances and an electrical recording, cannot establish which rhythm is responsible.

Palpitations describe the feeling of a heartbeat becoming unusually noticeable. People may describe fluttering, pounding, racing or a skipped beat in the chest, neck or throat. These sensations do not identify one particular arrhythmia. Sleep loss, stress, medicines and several medical conditions can produce similar experiences. Conversely, the absence of a dramatic sensation does not establish a reassuring diagnosis. Recurrent episodes, episodes lasting longer than a few minutes, or symptoms in someone with known heart disease or a relevant family history deserve medical assessment. The combination of symptoms and the circumstances matters more than finding the perfect word to describe the sensation.

The main rhythm problems are different conditions

Premature atrial and ventricular beats

A premature beat arrives earlier than the next expected heartbeat. A premature atrial contraction (PAC) starts in an upper chamber; a premature ventricular contraction (PVC) starts in a lower chamber. After the early beat, a brief pause and a stronger subsequent beat can create the impression that the heart missed a beat. The sensation alone cannot tell a PAC from a PVC. Occasional premature beats are common, and a reassuring assessment may lead to observation rather than treatment. However, persistent symptoms or frequent beats can justify an ECG, an ambulatory recording or an assessment of heart structure. The purpose is to determine what is happening and in what setting, rather than to treat every noticeable heartbeat as dangerous.

For ventricular premature beats, clinicians consider their frequency across a recording, their electrical appearance, symptoms and the condition of the heart muscle. A brief isolated finding and a frequent pattern associated with reduced pumping function are different clinical situations. In some people, frequent PVCs contribute to a weakening of the heart, making follow-up of ventricular function important. A percentage from a monitor report is therefore part of an assessment, not a stand-alone diagnosis or a universal treatment threshold. Selected patients need further imaging or specialist treatment; others can be monitored. This same attention to the heart muscle helps interpret ventricular tachycardia, because scarring and other structural abnormalities can provide a setting in which more consequential ventricular rhythms occur.

Supraventricular tachycardia and accessory pathways

Supraventricular tachycardia (SVT) describes fast rhythms that involve tissue above the ventricles. Many episodic SVTs begin and end abruptly, unlike the more gradual acceleration of ordinary sinus rhythm during exertion. The mechanism matters. In atrioventricular nodal re-entrant tachycardia (AVNRT), an electrical circuit involves pathways in or near the AV node. Atrioventricular re-entrant tachycardia (AVRT) involves an additional electrical connection, often called an accessory pathway. Atrial tachycardia starts from abnormal activity in the atria. These names explain why two people with apparently similar racing episodes may receive different advice. A clinician-taught maneuver may be part of an agreed plan for a diagnosed, stable episode. It is not a substitute for emergency assessment when warning symptoms occur, and this guide does not recommend neck massage or improvised self-treatment.

An accessory pathway can sometimes allow unusually rapid conduction to the ventricles, particularly when another atrial rhythm is present. That is one reason a medicine used for one fast rhythm may be unsuitable for another. Treatment decisions for recurrent SVT take account of the documented mechanism, episode frequency, symptom burden and the person’s preferences. Observation can be reasonable in selected circumstances; medicines or catheter ablation may be appropriate in others. Ablation is not always reserved for people who have tried every possible medicine. For several re-entrant rhythms, discussing it as an initial option is reasonable after the likely benefits and procedural risks are explained. An electrophysiologist can clarify which circuit is suspected and what a procedure would actually target.

There is also a newer, specifically prescribed option for selected adults with diagnosed paroxysmal SVT. In the United States, etripamil nasal spray, marketed as Cardamyst, received initial approval in 2025 for acute symptomatic PSVT episodes. This does not make it a general remedy for an unexplained racing pulse. Its prescribing information excludes several conditions, including specified heart failure, pre-excitation syndromes and certain conduction disorders, and warns about dizziness, low blood pressure and fainting. A treating clinician must determine suitability and provide an episode plan. Approval in the United States does not establish availability in every country. Anyone prescribed an episode treatment still needs to know which symptoms require immediate emergency help rather than continuing to wait at home.

Atrial fibrillation and atrial flutter

In atrial fibrillation (AF), electrical activity in the atria is disorganized. Atrial flutter usually involves a more organized circulating electrical pattern. Both require an actual rhythm diagnosis; the feel of a pulse is insufficient. Management can address three separate problems: controlling ventricular rate, restoring or maintaining a preferred rhythm, and preventing a clot-related stroke when indicated. A medicine that slows the pulse does not necessarily restore normal rhythm. An anticoagulant reduces clot-related risk but does not make the heartbeat regular. Not everyone with an arrhythmia needs an anticoagulant. In AF, the decision depends on estimated stroke risk, bleeding considerations and individual circumstances. Aspirin is not an equivalent substitute when anticoagulation is indicated. Mechanical heart valves and significant mitral valve narrowing also affect the choice of anticoagulant, so medication selection needs a clinician’s assessment.

AF care also changes over time. Symptoms, other illnesses and treatment goals should be reassessed rather than assuming the first plan will remain appropriate indefinitely. Someone may feel better after rhythm treatment while still having stroke-risk factors that matter. For planned cardioversion, clinicians consider how long AF may have been present and whether clot-prevention treatment or imaging is needed before restoring rhythm. Different guideline systems use different detailed pathways, making a single home timing rule misleading. Emergency treatment of an unstable patient is a separate situation. Longer-term anticoagulation decisions after an apparently successful ablation are also individualized and should not be made simply because the pulse feels normal. Do not start, stop or replace an anticoagulant based on symptoms alone.

Brief atrial episodes recorded by an implanted device also require interpretation. Their duration, confirmation and the person’s stroke risk affect the discussion. They are not automatically equivalent to clinically documented AF, and neither an implant alert nor a consumer watch notification alone means everyone should receive anticoagulation.

Slow rhythms, pauses and heart block

Bradycardia means a slow heart rate, but a slow rate is not automatically disease. Sinus-node dysfunction occurs when the heart’s usual pacemaker does not generate appropriate signals. It may cause pauses or an inadequate rate response when activity demands more circulation. Some people alternate between fast atrial rhythms and slow periods, sometimes called tachy-brady syndrome. For sinus-node dysfunction, there is no single minimum heart rate or pause duration that automatically means a pacemaker is needed. Establishing whether symptoms occur with the slow rhythm is important, as is looking for reversible explanations. Slow rhythms during sleep can also prompt consideration of sleep apnea. A low overnight reading by itself is not a universal indication for pacing.

Heart block concerns transmission of signals between the atria and ventricles rather than simply slow signal formation. Its seriousness depends on the type and extent of the conduction problem. Some acquired high-grade forms, when not explained by a reversible or physiological cause, can require pacing even without symptoms. This is an important exception to the idea that every pacing decision must first prove symptom correlation. Assessment also considers the heart’s pumping function and the broader clinical setting. Device choice is therefore more specific than deciding that a person “has a slow pulse.” The team needs to determine what electrical function requires support, how often pacing is expected to be used and which approach best balances benefit with procedural and longer-term risks.

Ventricular tachycardia and ventricular fibrillation

Ventricular tachycardia (VT) starts in the ventricles. A monitor may record a short, self-ending run, whereas sustained VT persists or requires treatment to stop it. These findings are not interchangeable with cardiac arrest, and their significance depends on symptoms, heart structure and other evidence. Someone with scarred heart muscle or reduced pumping function may have a different risk profile from someone with a particular ventricular rhythm in an otherwise structurally normal heart. Some VT causes immediate collapse, but a person can remain awake during other episodes. Ventricular fibrillation is different: the ventricles cannot produce effective circulation, and emergency resuscitation is needed. In selected people at risk of life-threatening ventricular rhythms, an implantable cardioverter-defibrillator can provide protection, but it does not remove every cause of arrhythmia or prevent every episode.

When family history changes the assessment

Fainting is a temporary loss of consciousness with several possible explanations; it should not automatically be labelled a rhythm problem or dismissed as one. The circumstances help determine the next investigation. Loss of consciousness during exertion, a concerning ECG or a family history of sudden unexplained death can raise concern about a cardiac cause. A description from someone who witnessed the event can help distinguish what happened before, during and after the collapse. Recovery does not erase the importance of the event. Evaluation is directed by the clinical history and findings, rather than routinely giving everyone the same test. If an arrhythmia is suspected, capturing the rhythm may be more informative than assuming a tilt-table test will answer the question.

Inherited rhythm disorders include long-QT syndrome, Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia, often shortened to CPVT. They affect electrical behavior in different ways and cannot be diagnosed from a symptom checklist. Specialist evaluation combines the personal and family history with appropriate clinical tests. Genetic testing is most useful when guided by the suspected condition and accompanied by counseling about what the result can and cannot show. A negative result does not always exclude inherited disease. A variant of uncertain significance is not automatically a disease-causing finding and should not be treated as a definitive predictive result for relatives. Family assessment may include clinical screening even when there is no useful genetic result. This differs from offering an unrestricted commercial genetic panel to everyone with palpitations.

How clinicians capture an intermittent rhythm

A resting ECG records a short sample of electrical activity. If the suspected rhythm comes and goes, a normal recording between episodes may simply miss it. Ambulatory monitors extend the observation period. A Holter or patch records over a defined interval, while other event-monitoring systems are suited to less frequent episodes; selected patients may need an implanted loop recorder for longer observation. Choosing a monitor depends on how often events occur and what the team is trying to establish. Recording symptoms alongside the tracing helps connect the experience to the electrical rhythm. A symptom episode without the suspected arrhythmia can also be useful information. It does not mean the symptoms were imaginary; it means the recorded episode needs a different explanation or interpretation.

Wearables can contribute information, but they do not all measure the same thing. An optical sensor estimates pulse changes from blood flow, while an ECG-capable device records an electrical signal, often from a single view. Movement, poor contact and technical limitations can affect results. An algorithm’s alert is a prompt for appropriate review, not a complete diagnosis or a prescription instruction. Conversely, a device that gives no alert cannot exclude every important rhythm. If a tracing is available, share the original recording and the circumstances with the clinician rather than relying only on the device’s label. Consumer recordings need interpretation in context, especially when a treatment decision could involve bleeding risk, medicines with significant adverse effects or an invasive procedure.

When AF is suspected, confirming the electrical rhythm is an important step. An irregular pulse can lead to an ECG, but it does not by itself establish AF. If episodes are intermittent and the initial ECG does not capture them, the timing of symptoms helps determine the recording approach. This is why a brief test that happens to be normal does not always finish the investigation. Equally, repeating a test without considering whether its duration matches the events may add little. The clinical question should stay explicit: is the aim to document a suspected rhythm, connect symptoms with it or characterize how often it occurs? These are related questions, but one recording does not necessarily answer all of them.

Testing someone with symptoms differs from screening a population that feels well. The United States Preventive Services Task Force concluded that evidence was insufficient to establish the overall balance of benefits and harms of AF screening in asymptomatic adults aged 50 years or older without a prior AF diagnosis. That finding does not mean a person should ignore palpitations, fainting or a clinician’s abnormal finding. It also does not mean that every older adult should buy a wearable or that one country’s screening assessment defines practice everywhere. Screening decisions consider whether finding additional cases improves meaningful health outcomes as well as the consequences of false alarms and subsequent treatment. An individual diagnostic investigation begins with a different question.

Blood tests, imaging and electrical studies answer different questions

The initial assessment usually brings together the symptom history, examination, medicines and relevant family history. Blood tests may look for contributors such as an electrolyte disturbance, thyroid disease or another suspected medical problem. There is no single laboratory panel that every person with a noticeable heartbeat must have. Clinicians choose investigations according to the presentation and what a result would change. An electrophysiology study is a more specialized investigation in which catheters record electrical signals from within the heart and help establish a rhythm’s mechanism. In selected circumstances, it can connect diagnosis with treatment during the same procedure. Its role is different from routine blood testing: it addresses an electrical pathway or circuit when that information is likely to guide management.

Imaging complements electrical recording rather than replacing it. An echocardiogram uses ultrasound to assess chambers, valves and pumping function. Selected patients need additional imaging, such as cardiac MRI, when more detail about the heart muscle or possible scar is relevant. An exercise test may help investigate symptoms linked to exertion or the heart’s response to activity, after the clinician has considered whether the test is safe and appropriate. A normal echocardiogram does not prove an intermittent arrhythmia is absent, because it answers a different question. Likewise, finding an arrhythmia on an ECG does not fully describe the structure of the heart. The tests work together when each is selected to resolve a specific uncertainty.

Treatment should match the rhythm and the person

Medicines and monitoring

Some rhythm medicines mainly slow conduction or reduce heart rate; others aim to prevent or terminate an abnormal rhythm. Their suitability depends on the actual diagnosis, the condition of the heart muscle and other health factors. Kidney or liver function can affect how medicines are handled, and combinations can change their effects. Some antiarrhythmic medicines can themselves provoke a different or more dangerous rhythm, which is why treatment may require ECGs, laboratory checks and review of new symptoms. Monitoring is part of safe treatment, not merely an administrative requirement. A medication that works well for someone else with palpitations may be inappropriate for your rhythm or underlying condition. Do not borrow treatment, change doses or abruptly stop a prescribed medicine without advice.

Drug-related arrhythmia is not limited to medicines prescribed for the heart. Prescription treatments, nonprescription products and combinations can alter rate, conduction or the time taken for the heart’s electrical system to reset. QT prolongation is one example of a mechanism, not a label that explains every drug-related rhythm problem. Risk can change when another medicine is added, organ function changes or electrolytes become abnormal. A useful review therefore includes supplements, cold remedies and recreational substances as well as regular prescriptions. The response should be a medication review with the prescriber or pharmacist, rather than independently stopping an important treatment. Knowing the complete list helps the team identify avoidable interactions while preserving treatment that is still necessary.

Cardioversion and ablation

Electrical cardioversion and emergency defibrillation are related but distinct treatments. For certain rapid rhythms when a pulse is present, clinicians can synchronize an electrical shock with the heartbeat. A planned procedure takes place with appropriate assessment and sedation when feasible. Defibrillation during cardiac arrest addresses shockable arrest rhythms, such as ventricular fibrillation, without that same synchronization. An AED assesses whether a shock is appropriate and gives prompts; it is not used to treat ordinary palpitations in an awake person. The choice belongs to the clinical situation, not simply to whether a heart rate seems high.

Cardioversion attempts to restore a different rhythm; catheter ablation targets electrical tissue involved in starting or maintaining a particular arrhythmia. In AF ablation, treatment commonly focuses on electrical triggers near the pulmonary veins, but the procedure and expected outcome depend on the individual situation. The decision weighs symptoms, other illnesses, previous treatment and the person’s priorities. Recurrence can occur, and some people need continued medicines or another procedure. Follow-up is important even after a successful result, both to assess rhythm outcomes and to review the wider treatment plan. Ablation should not be described as a guaranteed cure or an automatic reason to stop stroke-prevention treatment. The benefits and complications need to be discussed for the actual rhythm and procedure being proposed.

Ablation technologies also differ. Thermal methods use heat or cold to alter targeted tissue; pulsed-field ablation uses electrical pulses with a different mechanism of tissue injury. These distinctions can affect the procedure’s risk profile, but a newer technology is not automatically suitable for every arrhythmia or every patient. Pulsed-field treatment still has potential complications, including problems related to catheter access and other procedural risks; reports also describe issues such as hemolysis and coronary spasm in relevant settings. The choice depends on the indication, available technology and the experience of the treating team. A useful discussion asks which technique is proposed for this specific rhythm, why it is preferred and how its benefits and uncertainties compare with the alternatives.

Pacemakers, defibrillators and coordinated pacing

A pacemaker provides low-energy electrical stimulation when support for the heart’s rhythm is needed. It is different from a defibrillator designed to detect and treat selected dangerous ventricular rhythms, although some implanted systems combine functions. Implantation and recovery require planning, whether the system uses leads or a catheter-delivered device. A catheter-based implant is still an invasive procedure. After implantation, checks assess device function and help ensure its settings meet the person’s needs. Wound symptoms and recovery restrictions should be discussed with the implant team, because instructions vary with the procedure and device. Having a pacemaker also does not mean every later symptom must be caused by the device; new symptoms still need an appropriate clinical assessment.

For selected people, pacing also aims to improve how the ventricles activate together. Cardiac resynchronization therapy, or CRT, and conduction-system pacing are approaches intended to preserve or restore more coordinated contraction. The choice depends on factors such as pumping function and how much pacing is expected, rather than simply the presence of an arrhythmia. Evidence is stronger for some established CRT indications than for every newer pacing strategy. The practical point is that devices have different treatment goals: supporting a slow rhythm, protecting against certain dangerous rhythms and coordinating contraction are not identical tasks. An individualized explanation of the proposed system should include which goal it addresses and how its performance and the heart’s function will be followed over time.

Magnet-containing electronics require sensible precautions around implanted cardiac devices. The FDA advises keeping items such as phones and smartwatches at least six inches, or about 15 centimeters, away from an implanted device and avoiding a pocket directly over it. A close magnet can change how some devices operate. This advice does not mean that everyone with an implant must avoid ordinary electronics altogether. Follow the instructions for the particular device and ask the implant clinic about unfamiliar equipment or procedures. If interference is suspected, move the object away and seek advice as appropriate; significant symptoms still require urgent care. Device-specific guidance is more reliable than assuming that every implant has the same restrictions.

Triggers and associated conditions: useful changes without blanket rules

Sleep-disordered breathing can coexist with atrial arrhythmias, ventricular rhythms and slow rhythms. Breathing interruptions, oxygen changes and repeated sleep disruption can affect cardiovascular physiology, making sleep history relevant to some assessments. A clinician may recommend evaluation when the symptoms or circumstances suggest a sleep disorder. Treatment can have important benefits, but the association between sleep apnea and an arrhythmia is not proof that treating apnea will eliminate the rhythm problem. In particular, CPAP should not be presented as a guaranteed cure for AF or a substitute for other indicated treatment. The useful approach is to address both conditions appropriately and judge progress using symptoms, relevant sleep measures and the cardiac questions that prompted evaluation.

Caffeine advice needs similar context. A short randomized coffee study in generally healthy adults did not find a significant increase in its primary measure of premature atrial beats, but did observe more premature ventricular beats and less sleep during coffee consumption. The participants and short study duration limit what can be concluded for people with established rhythm disease. The study does not prove that coffee is safe for every patient, and it cannot be generalized to concentrated energy products. If symptoms appear related to caffeine, discuss the pattern and an individualized approach with the treating clinician. Avoid turning one person’s experience, or one brief trial, into either a universal ban or blanket reassurance about all stimulants.

Alcohol has more specific evidence in selected people with AF. A randomized trial of regular drinkers with AF found that an abstinence-focused strategy reduced recurrence and the amount of AF over follow-up compared with usual drinking. Most participants were men, and the findings do not establish the same effect for every rhythm or every pattern of alcohol use. Nevertheless, alcohol reduction is a meaningful topic to discuss when managing AF rather than dismissing it as unrelated lifestyle advice. It is not a substitute for necessary stroke prevention or rhythm treatment. People who may be dependent on alcohol need medical guidance about safe reduction, because withdrawal can itself be hazardous. The goal is a safe, realistic plan matched to the individual situation.

Exercise, competitive sport and pregnancy need their own context

An arrhythmia diagnosis does not automatically prohibit all exercise. Decisions depend on the rhythm, symptoms, underlying condition and the type of activity. A person with a reassuring assessment and occasional premature beats faces a different question from an athlete who loses consciousness during exertion. Exertional fainting or other concerning exercise-related symptoms requires cardiac evaluation before returning to competitive sport. Specialist assessment may consider how the rhythm behaves with activity and whether treatment changes the risk. Return-to-play decisions should include informed discussion and an emergency plan where relevant, rather than a blanket lifetime ban or indiscriminate clearance. This article cannot provide an individual exercise prescription, particularly when symptoms occur during training or the diagnosis remains uncertain.

Pregnancy can make the heartbeat more noticeable, but new or severe symptoms should not automatically be labelled a normal part of pregnancy. Assessment may include the history, examination and ECG, with particular attention to known heart disease and inherited rhythm conditions. Treatment needs to account for both maternal and fetal considerations. Medication safety during pregnancy is not identical to safety while breastfeeding, and entire drug classes should not be described as universally safe. Do not abruptly stop prescribed treatment after learning of a pregnancy. A coordinated cardiology and maternity team can review the options. When cardioversion is clinically needed, pregnancy alone is not a reason to withhold it; procedure decisions require appropriate specialist planning.

For someone with an established significant cardiac condition, a preconception review can identify issues that are easier to address before pregnancy. The plan may consider the specific arrhythmia, medication choices, monitoring and the support needed during delivery and afterward. Care does not necessarily end at birth: the postpartum period can be important in particular inherited syndromes, including long-QT syndrome. Breastfeeding introduces another set of medication considerations. These distinctions explain why advice given before pregnancy may need to be revisited later rather than carried forward unchanged. A personalized plan should specify who coordinates cardiac and obstetric care and how a change in symptoms will be assessed across pregnancy, recovery and feeding decisions.

Why follow-up remains part of treatment

Remote monitoring can transmit information from an implanted device and help the clinic identify certain problems between visits. It depends on a working connection, appropriate alert settings and a defined review process. It is not a real-time emergency-response service, and a successful transmission does not mean someone is immediately watching the rhythm. Ask the device clinic what to do if connectivity is lost and how routine alerts are handled. Keep a separate emergency plan for serious symptoms rather than sending a transmission and waiting for a response. Regular follow-up also allows the team to check the implant and reconsider settings as clinical needs change. The device, its monitoring system and emergency care each have different roles.

Our overview of cardiovascular conditions and care explains the wider setting in which rhythm problems may be assessed.

Tests at a glance

Video explanation

The following Yale Medicine video is retained as supplementary education. It does not replace individual clinical advice.